MRI pathway and TRUS-guided biopsy for detecting clinically significant prostate cancer

Comparison of Multiparametric Magnetic Resonance Imaging and Targeted Biopsy With Systematic Biopsy Alone for the Diagnosis of Prostate Cancer

“…Test accuracy measures were beyond the scope of this review, but a systemic review will be published soon. 32…”

“…The design of the included studies did not allow for calculation of test properties, such as sensitivity and specificity, because most patients did not undergo a reference standard procedure (ie, saturation biopsy or prostatectomy). Test accuracy measures were beyond the scope of this review, but a systemic review will be published soon …”

O papel dos microRNAs -23b/-27b na progressão do câncer de próstata resistente à castração: estudo in vivo

“…Este exame é capaz de avaliar a extensão local da doença e caracterizar áreas suspeitas, sendo muito útil em protocolos de vigilância ativa 17 . Pode ser indicada em nova biópsia quando houver suspeita persistente, apesar de biópsia prévia negativa 18 , e foi recentemente recomendada para direcionar biópsia diagnóstica inicial pela associação européia de urologia [19][20][21][22][23]…”